YAZ was approved by FDA for use as a hormonal contraceptive to prevent pregnancy, treatment of moderate acne (acne vulgaris) and a PMDD (Premenstrual Dysphoric Disorder). Regrettably, PMDD has been mistaken with the more common phenomena – PMS (Premenstrual Syndrome). However, they are not identical. PMS is a group of symptoms linked to the menstrual cycle women experience.


YAZ contains 3mg of DRSP (DROSPIRENONE)

On the other hand, PMDD, is recognized by the DSM-IV (Diagnostic & Statistical Manual of Mental Disorders) and requires five (5) or more of the criteria below be present in most menstrual cycles during a one (1) year period of time during specific time frames related to woman’s menstrual cycle.


  • markedly depressed mood, feelings of hopelessness, or self-deprecating thoughts
  • marked anxiety, tension, feelings of being “keyed up”, or “on edge”
  • marked affective lability (e.g., feeling suddenly sad or tearful or increased sensitivity to rejection)
  • persistent and marked anger or irritability or increased interpersonal conflicts
  • decreased interest in usual activities (e.g., work, school, friends, hobbies)
  • subjective sens of difficulty in concentrating
  • lethargy, easy fatigability, or marked lack of energy
  • marked change in appetite, overeating, or specific food cravings
  • hypersomnia or insomnia
  • a subjective sens of being overwhelmed or out of control
  • other physical symptoms, such as breast tenderness or swelling, headaches, joint or muscle pain, a sensation of “bloating”, weight gain
These symptoms must combine to literally cause a disturbance that markedly interferes with work, school, usual social activities, relationships or the result in the avoidance of social activity, decreased productivity and efficiency at work or school. As such, they must be a serious problem and be tracked as part of a “diagnosis” by a qualified professional.
Recent reports indicate that a significant amount of confusion between PMS and PMDD may have resulted from promotional advertisement materials, including TV ads, that effectively blurred the lines between PMS and PMDD. This confusion, as well as the failure to adequately underscore then known risks of DRSP (DROSPIRENONE) containing pills resulted in a series of FDA WARNING LETTERS and corrective advertisement. Some women may have asked to be put on a DRSP (DROSPIRENONE) containing birth control pill, like YASMIN or YAZ based upon their confusion of PMS and PMDD symptoms. Subsequently, they may have suffered injuries or side effects that were not adequately warned about, as underscored by new scientific data and pending FDA hearings.
Girls and Women that suffered a YAZ SIDE EFFECT may seek a CASE EVALUATION of their potential YAZ LAWSUIT.  Additional information regarding the FDA WARNING LETTERS, as well as a FREE CASE EVALUATION is available from the sponsor of this site through the requests for contact below.